Daridorexant 25 or 50 mg improved sleep parameters in patients with comorbid insomnia disorder and untreated mild obstructive sleep apnoea.
New Hope for Sleep Without Risking Breathing
This post hoc subgroup analysis of a Phase 3 randomized clinical trial evaluated daridorexant in patients with comorbid insomnia disorder an…
You lie in bed for hours, wide awake. You’re exhausted—but your mind won’t shut off.
PAP therapy reduces pulmonary arterial pressures in patients with severe OSA or OHS
Breathing therapy linked to lower lung pressure in severe sleep apnea patients
A meta-analysis of 733 patients with obstructive sleep apnoea or obesity hypoventilation syndrome found PAP therapy was associated with a me…
Positive airway pressure therapy lowers lung artery pressure in severe sleep apnea patients, with the biggest drops seen in those who alread…